2006 News Archive
Please browse our press releases below. These are all in Adobe Acrobat PDF format. If you do not have an appropriate PDF reader, please click here
ProStrakan increases focus on Specialty Pharma model with sale of its Drug Discovery Unit (ProSkelia) to Galapagos
22nd December 2006
ProStrakan announces the disposal of Zindaclin to Crawford Healthcare
12th December 2006
ProStrakan announces an exclusive licence agreement with Ferring to distribute Rectogesic and Tostran in CEE, Russia and CIS
11th December 2006
ProStrakan announces positive results from pivotal Phase III study on Sancuso (transdermal granisetron patch)
6th December 2006
ProStrakan announces first milestone in bone related diseases collaboration
6th December 2006
ProStrakan announces completion of US$9 million (£4.7 million) outright purchase of key worldwide rights to Rectogesic and Tostran
29th November 2006
ProStrakan announces an exclusive collaboration with Novartis in the field of bone related diseases
27th September 2006
ProStrakan announces US$9 million (£4.7 million) outright purchase of worldwide rights to Tostran and Rectogesic
27th September 2006
Interim results for the six months ended 30 June 2006
13th September 2006
ProStrakan announces an exclusive agreement with Gedeon Richter to distribute Rapinyl in CEE
25th July 2006
Holding in company - BlueCrest Capital Management LP
19th July 2006
ProStrakan announces exclusive licence and collaboration agreement with Amgen to develop and commercialise compounds for renal disease
13th July 2006
ProStrakan extends Tostrex and Rectogesic rights to Russia and the CIS
22nd June 2006
Result of resolutions passed at Annual General Meeting
11th May 2006
Annual information update for period 16 June 2005 up to and including 11 May 2006
11th May 2006
Annual Report 2005 and Annual General Meeting Circular and Notice 2006
13th April 2006
ProStrakan announces successful EU MRP conclusion for Tostrex
11th April 2006
Preliminary results for the year ended 31 December 2005
23rd March 2006
ProStrakan signs in-licensing agreement for Tabphyn
23rd March 2006
ProStrakan announces successful conclusion of EU MRP for Rectogesic
23rd March 2006
Progress with Sancuso and Tostrex development programmes
8th February 2006
EU's fastest growing healthcare company opens new global Headquarters
23rd January 2006
SHARE PRICE
